Open‑Angle Glaucoma – A Complete Patient Guide

Overview

Open‑angle glaucoma (OAG) is the most common form of glaucoma, a chronic eye disease that damages the optic nerve and can lead to irreversible vision loss. Unlike angle‑closure glaucoma, the drainage angle formed by the iris and cornea remains open; however, the trabecular meshwork (the eye’s drainage system) becomes less efficient, causing a gradual rise in intraocular pressure (IOP). Over time, the elevated pressure compresses the optic nerve fibers, producing characteristic visual field defects.

Who it affects: OAG typically develops slowly and is most prevalent in adults over age 40. It is slightly more common in people of African descent, who tend to develop the disease earlier and progress more rapidly, and in people of Asian descent, although the overall prevalence is lower compared with Caucasians.

Prevalence: According to the World Health Organization, glaucoma affects roughly 64 million people worldwide, and open‑angle glaucoma accounts for about **90 %** of cases.^{[1] CDC, 2022} In the United States, an estimated **3.1 million adults** have OAG, with prevalence increasing from 0.3 % in the 40‑49 age group to >4 % in those older than 80.^{[2] NIH, 2023}

Symptoms

Open‑angle glaucoma is often called the “silent thief of sight” because it usually produces no pain or obvious symptoms until moderate damage has occurred. The first signs are subtle changes in peripheral vision.

• Gradual loss of peripheral (side) vision: Patients may notice that objects at the edge of their visual field fade or that they need to turn their head more to see things.
• Tunnel vision: As the disease progresses, the visual field narrows, resembling looking through a tube.
• Difficulty seeing in low light: Night vision may worsen because peripheral rods are affected first.
• Haloes around lights: Rare in OAG but can appear if pressure spikes.
• Eye strain or fatigue: Some patients report eye tiredness from compensating for missed peripheral cues.
• Headaches: Typically only when IOP rises sharply (often due to medication non‑adherence).

Because central vision is usually preserved until late stages, many people are unaware they have glaucoma until routine eye testing reveals damage.

Causes and Risk Factors

Primary cause

The fundamental problem is impaired outflow of aqueous humor through the trabecular meshwork, leading to elevated IOP. In primary open‑angle glaucoma (POAG), the exact molecular cause is unknown, but genetic and environmental factors play a role.

Key risk factors

• Age: Risk doubles every decade after age 40.
• Family history: First‑degree relatives with glaucoma increase risk 2–4 times.^{[3] Mayo Clinic, 2022}
<
• Elevated intraocular pressure: IOP > 21 mm Hg is a major risk, though many patients have normal pressure (normal‑tension glaucoma).
• Ethnicity: African‑American descent carries a 5‑7 × higher risk; Asian descent has a slightly lower overall risk but higher risk for angle‑closure subtypes.
• Myopia (nearsightedness): Moderate to high myopia increases risk.
• Thin corneas: Central corneal thickness < 500 µm correlates with higher chance of progression.
• Systemic conditions: Diabetes, hypertension, and cardiovascular disease can influence optic nerve health.
• Long‑term corticosteroid use: Topical, oral, or inhaled steroids can raise IOP.
• Trauma or previous eye surgery: Can damage drainage structures.

Diagnosis

Because early disease is asymptomatic, regular eye exams are essential, especially for high‑risk groups.

Standard tests

• Tonometry: Measures intraocular pressure. Common devices include Goldmann applanation tonometer (gold standard) and non‑contact “air‑puff” tonometers.
• Ophthalmoscopy (optic nerve head exam): The clinician looks for cupping (enlarged optic disc) and thinning of the neuroretinal rim.
• Perimetry (visual field testing): Automated Humphrey or Octopus perimetry maps peripheral vision loss.
• Gonioscopy: Uses a special lens to view the drainage angle and confirm it is open.
• Optical coherence tomography (OCT): Provides high‑resolution images of retinal nerve fiber layer (RNFL) thickness; thinning indicates progressive damage.
• Pachymetry: Measures central corneal thickness to interpret IOP readings accurately.

Diagnostic criteria

Diagnosis typically requires:

1. Elevated IOP (≥21 mm Hg) or documented spikes.
2. Characteristic optic nerve head changes (increased cup‑to‑disc ratio, rim loss).
3. Corresponding visual field defects.

In normal‑tension glaucoma, IOP may be within normal range, but optic nerve damage and field loss are present.

Treatment Options

The goal of treatment is to lower IOP to a level that halts or slows further optic nerve damage. Management is lifelong and tailored to disease severity, patient age, comorbidities, and tolerance.

Medications

• Prostaglandin analogues (e.g., latanoprost, bimatoprost): First‑line; increase outflow through uveoscleral pathway. Once‑daily dosing.
• Beta‑blockers (e.g., timolol, betaxolol): Reduce aqueous production. Caution in asthma or severe COPD.
• Alpha‑agonists (e.g., brimonidine): Both decrease production and increase outflow; may cause dry mouth.
• Carbonic anhydrase inhibitors (e.g., dorzolamide, brinzolamide): Oral or topical; useful as add‑on therapy.
• Rho‑kinase inhibitors (e.g., netarsudil): Newer class improving trabecular outflow; can cause conjunctival hyperemia.

Adherence is critical; missing doses can raise IOP within days.

Laser procedures

• Selective Laser Trabeculoplasty (SLT): Low‑energy laser applied to trabecular meshwork; can reduce IOP 20‑30 % and may postpone or replace drops.
• Argon Laser Trabeculoplasty (ALT): Older technique, less commonly used now.

Surgical options

Considered when medication and laser fail to achieve target IOP.

• Trabeculectomy: Creates a new drainage pathway (bleb) under the conjunctiva.
• Glaucoma drainage devices (e.g., Ahmed, Baerveldt implants): Tubes shunt fluid to an external reservoir.
• Minimally invasive glaucoma surgery (MIGS): Stents (e.g., iStent) or micro‑shunts placed via a small incision; lower complication rates but modest IOP reduction.

Lifestyle & adjunct measures

• Regular aerobic exercise (e.g., brisk walking) can lower IOP modestly (1‑2 mm Hg).
• Limit caffeine intake; high caffeine can transiently raise IOP.
• Avoid smoking – it impairs ocular blood flow.
• Protect eyes from trauma (safety glasses).

Living with Open‑Angle Glaucoma

Effective management combines medical therapy, routine monitoring, and self‑care.

Daily management tips

• Medication routine: Use a pill‑box, set alarms, or link dosing to daily habits (e.g., brushing teeth).
• Eye‑drop technique: Tilt head back, pull lower eyelid down, apply one drop, close eye gently for 1 minute; avoid blinking excessively.
• Follow‑up schedule: Most patients need an exam every 3–12 months; high‑risk cases may require 2‑month visits.
• Vision aids: Use peripheral vision training, contrast‑enhancing glasses, or enlarged text devices if field loss progresses.
• Driving safety: Discuss any visual field deficits with your physician; many states require reporting vision‑related impairments.
• Support networks: Glaucoma foundations, local support groups, and vision‑rehabilitation services can provide emotional and practical help.

Prevention

While you cannot change age or genetics, several strategies may lower the risk of developing OAG or slow its progression.

• Regular eye exams: Adults ≥40 years should have a comprehensive dilated exam every 1–2 years; high‑risk individuals may need annual checks.
• Control systemic health: Manage diabetes, hypertension, and cholesterol with lifestyle changes and medication.
• Limit steroid exposure: Use the lowest effective dose, discuss alternatives with your doctor.
• Maintain a healthy weight and exercise: Obesity is linked to higher IOP.
• Protect eyes: Wear protective eyewear during sports or high‑impact work.

Complications

If untreated or inadequately controlled, open‑angle glaucoma can lead to serious outcomes.

• Progressive vision loss: Starts peripherally, advancing to central vision, ultimately causing blindness.
• Falls and injuries: Reduced peripheral vision raises risk of tripping or misjudging obstacles.
• Reduced quality of life: Difficulty driving, reading, or recognizing faces can lead to social isolation and depression.
• Psychological impact: Anxiety about vision loss is common; counseling and support groups are beneficial.

When to Seek Emergency Care

---

References:

1. World Health Organization. “Glaucoma.” 2022. https://www.who.int/health-topics/glaucoma#tab=tab_1
2. National Eye Institute (NEI). “Glaucoma Statistics.” 2023. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/glaucoma
3. Mayo Clinic. “Open-angle glaucoma.” 2022. https://www.mayoclinic.org/diseases-conditions/glaucoma/symptoms-causes/syc-20372839
4. American Academy of Ophthalmology. “Preferred Practice Pattern Guidelines – Primary Open‑Angle Glaucoma.” 2021.
5. Cleveland Clinic. “Glaucoma Treatment Options.” 2023.